Cronos Group (TSE:CRON) Trading Down 1.7% – What’s Next?

Cronos Group Inc. (TSE:CRON) shares fell 1.7% during mid-day trading on Friday . The stock traded as low as C$3.52 and last traded at C$3.53. 76,890 shares changed hands during mid-day trading, a decline of 53% from the average session volume of 164,441 shares. The stock had previously closed at C$3.59.

Cronos Group Price Performance

The firm has a market capitalization of C$1.35 billion, a price-to-earnings ratio of 32.09, a P/E/G ratio of 0.12 and a beta of 1.13. The company’s 50 day moving average is C$3.66 and its 200 day moving average is C$3.45. The company has a quick ratio of 24.01, a current ratio of 24.24 and a debt-to-equity ratio of 0.17.

Cronos Group (TSE:CRON) last announced its earnings results on Thursday, November 6th. The company reported C$0.07 earnings per share (EPS) for the quarter. The firm had revenue of C$50.60 million for the quarter. Cronos Group had a negative net margin of 42.65% and a negative return on equity of 4.40%. On average, equities research analysts anticipate that Cronos Group Inc. will post -0.26 earnings per share for the current fiscal year.

About Cronos Group

Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S.